<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/news" routerlinkactive="active" class="nav-link" href="/news">News</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">About GARD</a><a routerlink="/espanol" routerlinkactive="active" class="nav-link" href="/espanol">En Espan√µl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 5714 - Glycogen storage disease type 2</h1></div><div><p><b>Other Names: </b>Pompe disease, Acid maltase deficiency disease, Aglucosidase alfa, Alpha-1,4-glucosidase deficiency, Cardiomegalia glycogenica diffusa, Deficiency of alpha-glucosidase, GSD II, Deficiency of lysosomal alpha-glucosidase</p><p><b>Categories: </b><span> Heart Diseases</span><span> Nervous System Diseases</span><span> RDCRN</span><!----></p><p><b>This disease is grouped under: </b>Glycogen storage disease</p><p><b>Summary: </b><span><strong>Glycogen storage disease type 2</strong>, also known as Pompe disease or acid maltase&nbsp;deficiency disease, is&nbsp;an inherited metabolic disorder.[864][865][866] While glycogen storage&nbsp;disease type 2&nbsp;is a single disease, it may be classified in 2 forms according to the rates of disease progression, its severity and the age at which symptoms start. The classic infantile-onset starts before 12 month of age and involves the heart muscle (myocardiopathy). The later-onset form may start before 12 months of age (non-classic infantile-onset), or after 12 months of age, but does not affect the heart. Muscle weakness is a main symptom in all forms. The infantile-onset is the most severe form and, if untreated, it may lead to death from heart failure in the first year of life. The late-onset form is usually milder, but if untreated may lead to severe breathing problems.[864][11724]&nbsp;<br>
<br>
Glycogen storage disease type 2 is caused by variants (mutations) in the <em>GAA</em> gene which have instructions to produce the enzyme acid alpha-glucosidase (acid maltase), needed to break down glycogen, a substance that is a source of energy for the body. The enzyme deficiency results in the accumulation of glycogen inside lysosomes, structures within cells that break down waste products within the cell. Accumulation of glycogen in certain tissues, especially muscles, impairs their  function.[864][865][866]<br>
<br>
In 2006,&nbsp;the U.S. Food and Drug Administration (FDA) approved the enzyme replacement therapy Myozyme as a treatment for all patients with&nbsp;glycogen storage&nbsp;disease type 2. Another similar drug called Lumizyme has recently been approved for the treatment this disease.[864][866][8904]&nbsp;Additional treatment of Pompe disease is symptomatic and supportive and may include respiratory and feeding support and physical therapy.[864]<br>
&nbsp;</span></p><div><b>Organizations: </b><ul><li><span><a href="org.url">Metabolic Support UK</a></span><br><span>5 Hilliards Court</span><br><span>Chester , CH4 9QP</span><br><!----><!----></li><li><span><a href="org.url">Association for Glycogen Storage Disease UK</a></span><br><span>PO Box 1232</span><br><span> , </span><br><!----><!----></li><li><span><a href="org.url">Acid Maltase Deficiency Association (AMDA)</a></span><br><span>P.O. Box 700248</span><br><span>San Antonio TX, 78270</span><br><!----><!----></li><li><span><a href="org.url">Muscular Dystrophy Association</a></span><br><span>222 S Riverside Plaza</span><br><span>Chicago IL, 60606</span><br><!----><!----></li><li><span><a href="org.url">International Pompe Association</a></span><br><span>Paula Waddell, c/o VSN</span><br><span> , </span><br><!----><!----></li><!----></ul></div><div><b>Learn More</b><ul><li><span><a href="http://www.omim.org/232300" target="_blank">Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br>
</span></li><li><span><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&amp;cmd=Display&amp;dopt=omim_pubmed_calculated&amp;from_uid=232300" target="_blank">PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Glycogen storage disease type 2. Click on the link to view a sample search on this topic.</span></li><li><span><a href="http://www.clinicaltrials.gov/ct2/results?cond=%22Glycogen+storage+disease+type+2%22" target="_blank">ClinicalTrials.gov</a> lists trials that are related to Glycogen storage disease type 2. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br>
<br>
<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em></span></li><li><span><a href="http://www.ghr.nlm.nih.gov/condition=pompedisease" target="_blank">Genetics Home Reference (GHR)</a> contains information on Glycogen storage disease type 2. This website is maintained by the National Library of Medicine.<br>
</span></li><li><span>The <a href="https://www.asgct.org/education" target="_blank">American Society of Gene &amp; Cell Therapy</a> provides information on the treatment of genetic diseases.</span></li><li><span><a href="https://www.babysfirsttest.org/newborn-screening/conditions/pompe" target="_blank">Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.</span></li><li><span>The&nbsp;<a href="https://www.rarediseasesnetwork.org/ldn" target="_blank">Lysosomal Disease Network</a>&nbsp;is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The&nbsp;Lysosomal Disease Network&nbsp;has a registry for patients who wish to be contacted about clinical research opportunities.<br></span></li><li><span>The <a href="http://www.fda.gov/bbs/topics/NEWS/2006/NEW01365.html " target="_blank">U.S. Food and Drug Administration</a> (FDA) provides information about an FDA-approved treatment for Pompe disease called&nbsp;Myozyme through a 2006 Press Release. To view this information, click on the above link.</span></li><li><span>The <a href="https://www.lsdregistry.net/pomperegistry/ " target="_blank">Pompe Registry</a> supports research for Glycogen storage disease type 2 by collecting information about patients with this diagnosis. You can join the registry to share your information with researchers and receive updates about participating in new research studies. <a href="https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries" target="_blank">Learn more about registries.</a><br>
<br></span></li><li><span>The <a href="https://www.acmg.net/StaticContent/StaticPages/Pompe_Disease.pdf" target="_blank">American College of Medical Genetics (ACMG)</a> provides education, resources, and a voice for the medical genetics profession.&nbsp; To make genetic services available to and improve the health of the public, the ACMG promotes the development and implementation of methods to diagnose, treat and prevent genetic diseases. In an effort to fulfill its mission, the ACMG performs many tasks, including developing clinical practice guidelines.&nbsp; In May 2006, the ACMG Work Group on Management of Pompe Disease released a ACMG Practice Guideline titled "Pompe disease diagnosis and management guideline." To view this practice guideline, visit the link above.</span></li><li><span>Van den Hout, et al., <a href="http://pediatrics.aappublications.org/cgi/reprint/113/5/e448?maxtoshow=&amp;amp;amp;HITS=10&amp;amp;amp;hits=10&amp;amp;amp;RESULTFORMAT=&amp;amp;amp;fulltext=pompe&amp;amp;amp;searchid=1&amp;amp;amp;FIRSTINDEX=0&amp;amp;amp;volume=113&amp;amp;amp;issue=5&amp;amp;amp;resourcetype=HWCIT " target="_blank">Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human {alpha}-Glucosidase From Milk</a>, Pediatrics 2004;113: e448-e457.</span></li><li><span>Talsma, et al.,&nbsp; <a href="http://pediatrics.aappublications.org/cgi/reprint/109/4/e65?maxtoshow=&amp;amp;amp;HITS=10&amp;amp;amp;hits=10&amp;amp;amp;RESULTFORMAT=&amp;amp;amp;fulltext=pompe&amp;amp;amp;searchid=1&amp;amp;amp;FIRSTINDEX=0&amp;amp;amp;volume=109&amp;amp;amp;issue=4&amp;amp;amp;resourcetype=HWCIT " target="_blank">A Rare Presentation of Childhood Pompe Disease: Cardiac Involvement Provoked by Epstein-Barr Virus Infection</a>. <em>Pediatrics</em> 2002;109:e65.</span></li><li><span>To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href="http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx" target="_blank">American College of Medical Genetics</a> and the&nbsp;<a href="https://www.findageneticcounselor.com/" target="_blank">National Society of Genetic Counselors</a>. If you need additional help, <a href="https://rarediseases.info.nih.gov/about-gard/contact-gard">contact a GARD Information Specialist</a>. You can also&nbsp;<a href="https://ghr.nlm.nih.gov/primer#consult" target="_blank">learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.</span></li><li><span>The <a href="http://www.ncbi.nlm.nih.gov/gtr/conditions/C0017921" target="_blank">Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br>
</span></li><li><span>The <a href="https://rarediseases.org/rare-diseases/pompe-disease/" target="_blank">National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br>
</span></li><li><span>The <a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Pompe-Disease-Information-Page" target="_blank">National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.</span></li><li><span><a href="http://emedicine.medscape.com/article/947870-overview" target="_blank">Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br>
</span></li><li><span>The <a href="https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022280" target="_blank">Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href="http://www.ssa.gov/compassionateallowances/index.htm" target="_blank">Compassionate Allowances</a> and <a href="https://www.ssa.gov/benefits/disability/" target="_blank">applying for Social Security disability</a> is available online.</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=365" target="_blank">Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br>
</span></li><li><span>An  <a href="https://www.acmg.net/PDFLibrary/Pompe.pdf" target="_blank">ACTion (ACT) sheet</a> is available for this condition that describes the short-term actions a health professional should follow when an infant has a positive newborn screening result. ACT sheets were developed by experts in collaboration with the American College of Medical Genetics.</span></li><li><span><a href="http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=gsd2" target="_blank">GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br>
</span></li><li><span>An <a href="https://www.acmg.net/PDFLibrary/Pompe-Algorithm.pdf" target="_blank">Algorithm</a> flowchart is available for this condition for determining the final diagnosis in an infant with a positive newborn screening result. Algorithms are developed by experts in collaboration with the American College of Medical Genetics.</span></li><li><span>The <a href="https://rarediseases.org/physician-guide/pompe-disease/" target="_blank">NORD Physician Guide</a> for Glycogen storage disease type 2 was developed as a free service of the National Organization for Rare Disorders (NORD) and it's medical advisors. &nbsp;The guides provide a resource for clinicians about specific rare disorders to facilitate diagnosis and treatment of their patients with this condition.&nbsp;</span></li><li><span>The <a href="https://monarchinitiative.org/disease/Orphanet:365" target="_blank">Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch‚Äôs tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.</span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/">NCATS Home</a></div><div class="col"><a href="javascript: void(0)">Site Map</a></div><div class="col"><a href="javascript: void(0)">Browse Glossary A-Z</a></div><div class="col"><a href="javascript: void(0)">Privacy Notice</a></div><div class="col"><a href="javascript: void(0)">Disclaimer</a></div><div class="col"><a href="javascript: void(0)">Accessibility</a></div><div class="col"><a href="javascript: void(0)">FOIA </a></div><div class="col"><a href="javascript: void(0)">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>
<script src="runtime.e227d1a0e31cbccbf8ec.js" defer=""></script><script src="polyfills.1aefc75bf7d5acb269d2.js" defer=""></script><script src="main.f870601fdb5bc988c829.js" defer=""></script>
<script id="ScullyIO-transfer-state"></script><script src="js/custom.js"></script>

</body></html>